<?xml version="1.0" encoding="UTF-8"?>
<ref id="CR63">
 <label>63.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Migone</surname>
    <given-names>TS</given-names>
   </name>
   <name>
    <surname>Subramanian</surname>
    <given-names>GM</given-names>
   </name>
   <name>
    <surname>Zhong</surname>
    <given-names>J</given-names>
   </name>
   <name>
    <surname>Healey</surname>
    <given-names>LM</given-names>
   </name>
   <name>
    <surname>Corey</surname>
    <given-names>A</given-names>
   </name>
   <name>
    <surname>Devalaraja</surname>
    <given-names>M</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>Raxibacumab for the treatment of inhalational anthrax</article-title>
  <source>N Engl J Med</source>
  <year>2009</year>
  <volume>361</volume>
  <fpage>135</fpage>
  <lpage>144</lpage>
  <pub-id pub-id-type="doi">10.1056/NEJMoa0810603</pub-id>
  <?supplied-pmid 19587338?>
  <pub-id pub-id-type="pmid">19587338</pub-id>
 </element-citation>
</ref>
